FAM133B and urinary bladder carcinoma: However, many oncogene variants are not equivalent to a WES analysis of human, and canine bladder cancers identified novel mutations in FAM133B, RAB3GAP2, and ANKRD52 that are unique to canine bladder cancer, emphasizing the need to understand the biological differences in origin13.